P

Pharmaprop.bxl

BE0804.643.803

About Pharmaprop.bxl

Pharmaprop.bxl is a private limited company (BV/SRL) based in Brussel, founded in 2023. For the 2024 financial year, Pharmaprop.bxl reported a loss of €2,163. Revenue was not published, which is common for abbreviated accounts. The gross margin came to €50,325. Equity is negative (-€1,163): liabilities exceed assets.

Juridical situation
Normal situation
Company number
0804.643.803
Founding date
Founded on 08-08-2023
EUID number
BEKBOBCE.0804.643.803
Type of enterprise
Rechtspersoon
Location
Zavelput 17 Brussel 1000
Juridical form
BV — Private limited company (BV/SRL)

Financial ratios

Profit
€ -2K
Equity
€ -1K
Gross margin
€ 50K
Health
Solvability > 25%
-0.1%
Liquidity > 1.0
0.13
Profitability > 0%
186.0%
2024
Gross margin
€ 50K
EBITDA
€ 46K
Profit
€ -2K
Equity
€ -1K
Solvability
-0.13%
Debt
€ 884K
Cash
€ 8K

Frequently asked questions

Answers to the most common questions about Pharmaprop.bxl, based on official government data and the filed annual accounts.

What is the VAT number of Pharmaprop.bxl?

The VAT number of Pharmaprop.bxl is BE0804.643.803.

When was Pharmaprop.bxl established?

Pharmaprop.bxl was founded in 08-08-2023.

What is the official address of Pharmaprop.bxl?

The official address of Pharmaprop.bxl is Zavelput 17 Brussel 1000.

What is the legal form of Pharmaprop.bxl?

The juridical form of Pharmaprop.bxl is Private limited company (BV/SRL).

What is the annual revenue of Pharmaprop.bxl?

The 2024 accounts of Pharmaprop.bxl do not report revenue. Smaller companies that file abbreviated accounts are not required to publish it.

Is Pharmaprop.bxl a reliable company?

Pharmaprop.bxl is a registered Rechtspersoon with company number 0804.643.803 and can be verified through the official CBE database.

What is the credit limit of Pharmaprop.bxl?

The estimated credit limit of Pharmaprop.bxl is €36,633.

Is Pharmaprop.bxl still active?

Pharmaprop.bxl currently has the status "Normal situation" and is active.

Further reading

View all insights

Sources